Epanutin (phenytoin) oral suspension is due to be out of stock from 2 March until June 2020.
While Epanutin oral suspension is out of stock, Pfizer will be importing a Canadian version of phenytoin oral suspension called Dilantin-30.
If you usually take Epanutin oral suspension, and are due to run out before June 2020, contact your GP for advice.
The Department of Health and Social Care (DHSC) has advised GPs to switch patients who don’t have enough Epanutin to Dilantin-30, until Epanutin is back in stock. Dilantin-30 contains the same active ingredient, and the DHSC says it can be considered equivalent to Epanutin.
You should not need any changes to your dose or frequency of your medicine when taking Dilantin-30. However, the Canadian patient information leaflet that comes with Dilantin-30 has different dosing information compared to the Epanutin leaflet.
It’s important to follow your doctor’s instructions for taking Dilantin-30, even if these are different from the dosing information on the leaflet.
If you or your GP do not feel Dilantin-30 is right for you, your GP should get advice from your epilepsy specialist.